This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Synopsys, Ansys settle with US FTC; deal review pending in China

By Ilana Kowarski ( May 29, 2025, 01:12 GMT | Insight) -- Semiconductor technology developer Synopsys’ proposed $35 billion acquisition of software creator Ansys has been conditionally cleared by the US Federal Trade Commission, which imposed a divestiture remedy to resolve antitrust concerns about the transaction. Meanwhile, Synopsys Chief Executive Sassine Ghazi announced today during an earnings call that his company’s Ansys purchase has just a single regulatory hurdle left to clear — a requirement to gain approval from China’s State Administration for Market Regulation, with which the company is "working cooperatively and actively negotiating."Semiconductor technology developer Synopsys’ proposed $35 billion acquisition of software creator Ansys has been conditionally cleared by the US Federal Trade Commission, which imposed a divestiture remedy to resolve antitrust concerns about the transaction....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login